Published in J Antimicrob Chemother on December 01, 1983
Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients. Antimicrob Agents Chemother (1985) 1.21
Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother (1986) 1.02
Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I). Antimicrob Agents Chemother (2002) 0.77
Comparison of micro-ID, API 20E, and conventional media systems in identification of Enterobacteriaceae. J Clin Microbiol (1978) 7.65
IgG on lymphocyte surfaces; technical problems and the significance of a third cell population. J Immunol (1975) 4.92
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med (1970) 2.94
Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties. Scand J Immunol (1976) 2.74
Comparison of rapid identification assays for Staphylococcus aureus. J Clin Microbiol (1984) 2.62
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med (1983) 2.17
Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol (1983) 2.11
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Antimicrob Agents Chemother (1985) 2.02
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother (1990) 1.96
dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. J Biol Chem (1993) 1.90
Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol (1983) 1.89
Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone. Clin Infect Dis (1998) 1.80
Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum (1998) 1.79
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66
Stimulatory effect of counterflow centrifugal elutriation in large-scale separation of peripheral blood monocytes can be reversed by storing the cells at 37 degrees C. J Clin Apher (1991) 1.61
Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect Immun (1992) 1.58
Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med (1979) 1.58
Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia (2000) 1.55
The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol (1978) 1.52
Multicenter in vitro evaluation of SM-7338, a new carbapenem. Antimicrob Agents Chemother (1989) 1.50
Bacteremia after liver biopsy. Arch Intern Med (1973) 1.49
Correlation studies of entero-set 20, API 20E and conventional media systems for Enterobacteriaceae identification. J Clin Microbiol (1981) 1.48
T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells. J Exp Med (1996) 1.44
Enzyme-linked immunosorbent assay for screening monoclonal antibody production using enzyme-labeled second antibody. Methods Enzymol (1983) 1.42
Natural killer funciton in systemic lupus erythematosus. Arthritis Rheum (1980) 1.41
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother (1984) 1.40
Periodic fever. Diagnostic and therapeutic problems. JAMA (1974) 1.40
Intracranial abnormalities requiring emergency treatment: identification by a single midline tomographic slice versus complete CT of the head. South Med J (1992) 1.39
Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proc Natl Acad Sci U S A (1981) 1.39
Shigellosis in day-care centres. Lancet (1975) 1.38
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
The 1970 epidemic of diphtheria in San Antonio. Ann Intern Med (1971) 1.31
Transient myocardial ischemia of the newborn infant: a form of severe cardiorespiratory distress in full-term infants. J Pediatr (1972) 1.29
Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J Med Microbiol (1983) 1.29
2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache (2001) 1.28
Equating the MOS SF36 and the LSU HSI Physical Functioning Scales. J Outcome Meas (1997) 1.27
Human lymphocytes bearing "Ia-like" antigens; absence in patients with infantile agammaglobulinemia. J Immunol (1977) 1.26
Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum. Diagn Microbiol Infect Dis (1988) 1.26
Parallel synthesis of immunoglobulins and J chain in pokeweed mitogen-stimulated normal cells and in lymphoblastoid cell lines. J Exp Med (1977) 1.25
Mycoplasma-dependent activation of normal lymphocytes: mitogenic potential of mycoplasmas for mouse lymphocytes. Infect Immun (1977) 1.24
Cefamandole therapy in anaerobic infections. Antimicrob Agents Chemother (1979) 1.22
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis (1991) 1.21
Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure. Am J Med (1981) 1.20
Effect of hemodialysis and renal failure on serum and urine concentrations of cephapirin sodium. Antimicrob Agents Chemother (1972) 1.17
In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents. J Antimicrob Chemother (1990) 1.15
Unusual manifestations of invasive pneumococcal infection. Am J Med (1999) 1.14
Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates. J Clin Microbiol (1987) 1.13
Study of teaching residents how to teach. J Med Educ (1988) 1.13
Skin and soft tissue infections in critical care. Crit Care Clin (1998) 1.13
Chronic postrheumatic-fever (Jaccoud's) arthritis. Case report with the rheumatoid factor and a family history of rheumatoid arthritis. Arch Intern Med (1967) 1.12
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrob Agents Chemother (1990) 1.10
Comparison of various tests for Fc receptors on different human lymphocyte sub populations. Clin Exp Immunol (1979) 1.10
Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache (2001) 1.10
Mycoplasma-dependent activation of normal lymphocytes: induction of a lymphocyte-mediated cytotoxicity for allogeneic and syngeneic mouse target cells. Infect Immun (1977) 1.09
Evaluation of a teaching skills improvement programme for residents. Med Educ (1988) 1.09
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1. J Infect Dis (1996) 1.08
Candidal suppurative peripheral thrombophlebitis. Ann Intern Med (1982) 1.08
Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J Pharmacol Exp Ther (2000) 1.07
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone. Antimicrob Agents Chemother (1981) 1.07
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing. Diagn Microbiol Infect Dis (1988) 1.07
Results of a clinical trial of cefoxitin, a new cephamycin antibiotic. Antimicrob Agents Chemother (1977) 1.04
Hypoimmunoglobulinemia with normal T cell function in female siblings. Clin Immunol Immunopathol (1977) 1.03
Surface markers of complement receptor lymphocytes. J Clin Invest (1978) 1.03
Interferon-induced differentiation of U937 cells. Comparison with other agents that promote differentiation of human myeloid or monocytelike cell lines. J Clin Invest (1983) 1.02
In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle (1978) 1.02
Growth and cytopathology of Mycoplasma synoviae in chicken embryo cell cultures. Infect Immun (1975) 1.02
Meningitis caused by Campylobacter fetus ssp jejuni. Br Med J (1980) 1.01
Role of imipenem/cilastatin in the treatment of soft tissue infections. Am J Med (1985) 1.01
Elevated mannose levels detected by gas-liquid chromatography in hydrolysates of serum from rats and humans with candidiasis. J Clin Microbiol (1982) 1.01
Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin. Hepatology (2001) 1.00
In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels. Diagn Microbiol Infect Dis (1995) 1.00
Cefamandole and cefoxitin. Ann Intern Med (1985) 1.00
Endocarditis caused by Erysipelothrix insidiosa. Am J Clin Pathol (1973) 0.99
Microfilament assembly modulates phospholipase C-mediated signal transduction by the TCR/CD3 in murine T helper lymphocytes. J Immunol (1992) 0.99
Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol (1994) 0.99
Scarlet fever and necrotizing fascitis caused by coagulase-positive hemolytic Staphylococcus aureus, phage type 85. Ann Intern Med (1973) 0.99
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. J Antimicrob Chemother (1986) 0.98
The chemistry of acetaldehyde-protein adducts. Alcohol Alcohol Suppl (1991) 0.98